After hours of emotional testimony and sharp back‑and‑forth, the Florida Senate on Tuesday pushed a controversial "Medical Freedom" proposal one step closer to the floor. Lawmakers voted 10–7 to move SB 1756 out of committee, sending it to the Senate Rules Committee and keeping the measure very much alive this session. The bill would broaden nonmedical vaccine exemptions for K‑12 students, add new consent rules for vaccinators, and let pharmacists hand out ivermectin to adults without a prescription while seeking liability protections. Backers frame it as a win for parental rights; critics warn it could punch holes in herd immunity and set the stage for future outbreaks.
Sen. Clay Yarborough, R‑Jacksonville, cast the bill as a way to bolster transparency and give parents more say in medical decisions for their kids. But not every Republican was on board. According to CBS Miami, Sen. Gayle Harrell, R‑Stuart, labeled the measure "dangerous" and warned it could force physicians to relearn how to treat diseases that had become rare thanks to vaccines. Senators also sparred over the ivermectin language and whether parents opting out of shots would receive the same state‑approved vaccine information as parents who say yes.
What’s in the bill
Per the Florida Senate, SB 1756, formally titled the "Medical Freedom Act," would change how vaccines for minors are handled across the state. Health care practitioners and paramedics would have to give parents state‑approved information on vaccine risks and benefits and obtain a signed acknowledgment before vaccinating a child. The measure creates a new "conscience" exemption that would let parents opt their children out of school‑required vaccines, trims the surgeon general’s authority to mandate vaccines during a declared public‑health emergency, and authorizes behind‑the‑counter dispensing of ivermectin to adults while granting pharmacists civil immunity. The committee substitute and bill history indicate the proposal would take effect July 1, 2026, if it becomes law.
Context: rulemaking and falling coverage
The legislation lands as the Florida Department of Health is already rethinking which shots kids need to attend school. The agency has opened rulemaking to revisit several school‑entry vaccine requirements, including hepatitis B, varicella, Hib and pneumococcal immunizations. As reported by WUSF, DOH held workshops and a public hearing late last year as it works on updates to Rule 64D‑3.046.
At the same time, national numbers are heading in the wrong direction. CDC SchoolVaxView data show kindergarten vaccination coverage has dipped in recent years, while exemptions have ticked up. Federal reporting warns that declining rates and rising opt‑outs increase the risk of outbreaks, and public‑health experts say that broader backdrop is very much in the room as lawmakers debate how far to go with exemptions and parental opt‑outs.
Next stops and the House companion
For now, SB 1756’s next destination is the Senate Rules Committee. If it clears Rules, it could land on the Senate floor for a full vote. Across the rotunda, the House is weighing a more aggressive version. HB 917 would not only expand exemptions, it would also bar health care providers from refusing patients based on vaccination status and require doctors to accept all patients regardless of vaccine history. Coverage by the News Service of Florida notes that First Lady Casey DeSantis and Surgeon General Joseph Ladapo have publicly urged lawmakers to press ahead with the related House measures.
Legal and public‑health stakes
The bill’s liability shields for pharmacists and tighter limits on emergency vaccination orders represent deliberate legal shifts in how Florida could respond to outbreaks, according to committee documents and the bill text. The decision to call out ivermectin, in particular, has turned up the political heat. Professional groups such as the AMA and federal COVID‑19 guidance pages have repeatedly urged caution about using ivermectin to treat viral illnesses, yet the drug now sits at the center of this policy fight.
Observers warn that layering these statutory changes on top of ongoing administrative rulemaking could invite legal challenges and raise fresh questions about federal funding and outbreak response if immunization coverage continues to erode. The stakes are not just theoretical for schools and clinics that remember how quickly routine childhood diseases can find gaps in vaccine walls.
Whatever lawmakers ultimately decide, the proposal is already reshaping conversations in pediatric offices, school district meetings and at pharmacy counters across Florida. This session will test how far the legislature is willing to go in redefining the line between parental autonomy and public‑health protection, with the Senate Rules Committee now holding the next set of amendments that could decide SB 1756’s fate.
